Notably, our previous study showed that the interaction of microseminoprotein (MSMP), a CCR2 ligand, with CCR2 plays an important role in promoting adaptive resistance to AVA in ovarian cancer models (Mitamura et al. 2018). The gene discussed is CCR2; the disease is ovarian carcinoma.